Literature DB >> 7288435

Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics.

C J Fowler, A Carlsson, B Winblad.   

Abstract

In the pons of autopsy cases who had suffered from chronic schizophrenic or nonschizophrenic psychoses, an increased activity of monoamine oxidase -B but not -A was found, as compared with age-matched controls. Consequently, the ratio of the activities of MAO-B : MAO-A was elevated in the cases of psychosis. There was no significant difference in enzyme activities between schizophrenic and nonschizophrenic psychoses. Lobotomy appeared not to influence the monoamine oxidase activity. Increased ratios of the activities of MAO-B : MAO-A in various brain parts of chronic schizophrenics in comparison with age-matched controls was found in the previously published data of Eckert et al (1980) and Schwartz et al. (1974) but not Crow et al. (1979). The mechanism underlying the change in enzyme activities is unclear. There seems to exist an association between an increased monoamine oxidase-B activity and degenerative processes in the brain resulting in loss of neuronal activity. The change observed may be linked either to pathological processes associated with chronic psychosis or to long-term treatment with neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288435     DOI: 10.1007/BF01253093

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  25 in total

1.  Multiple forms of brain monoamine oxidase in schizophrenic and normal individuals.

Authors:  M A Schwartz; R J Wyatt; H Y Yang; N H Neff
Journal:  Arch Gen Psychiatry       Date:  1974-10

2.  Neuropathological investigation of 28 brains from patients with dyskinesia.

Authors:  E Christensen; J E Moller; A Faurbye
Journal:  Acta Psychiatr Scand       Date:  1970       Impact factor: 6.392

3.  Studies on the nature of the increased monoamine oxidase activity in the rat heart after adrenalectomy.

Authors:  B A Callingham; R Laverty
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

4.  Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.

Authors:  H L White; A T Glassman
Journal:  J Neurochem       Date:  1977-12       Impact factor: 5.372

5.  Evidence for a single catalytic binding site on human brain type B monoamine oxidase.

Authors:  J A Roth
Journal:  J Neurochem       Date:  1976-11       Impact factor: 5.372

6.  The effect of age on the activity and molecular properties of human brain monoamine oxidase.

Authors:  C J Fowler; A Wiberg; L Oreland; J Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 7.  Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.

Authors:  R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

8.  Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.

Authors:  T J Crow; H F Baker; A J Cross; M H Joseph; R Lofthouse; A Longden; F Owen; G J Riley; V Glover; W S Killpack
Journal:  Br J Psychiatry       Date:  1979-03       Impact factor: 9.319

9.  Tardive dyskinesia and dementia.

Authors:  O O Famuyiwa; D Eccleston; A A Donaldson; R F Garside
Journal:  Br J Psychiatry       Date:  1979-12       Impact factor: 9.319

10.  Titration of human brain monoamine oxidase -A and -B by clorgyline and L-deprenil.

Authors:  C J Fowler; L Oreland; J Marcusson; B Winblad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

View more
  2 in total

1.  Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.

Authors:  J J Mann; R D Kaplan; E D Bird
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Authors:  Beatriz Camarena; Ana Fresán; Alejandro Aguilar; Raúl Escamilla; Ricardo Saracco; Jorge Palacios; Alfonso Tovilla; Humberto Nicolini
Journal:  ISRN Psychiatry       Date:  2012-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.